On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022. This is an expansive piece of legislation and covers a very wide variety of policies. This Health Policy in Transit will briefly describe the provisions related to prescription drugs, specifically those that affect employer plan sponsors.

A recent study from the Patient-Centered Outcomes Research Institute (PCORI) reinforces the positive impact of aspirin, regardless of dose, in preventing heart attacks and strokes in people living with heart disease. This Action Brief equips employers with action steps to help employees with CVD make informed decisions about aspirin dosing.

With the COVID-19 vaccine rollout in high gear, misinformation has flooded communication channels and led to widespread concern and vaccine hesitancy. Employers play a key role in debunking the abundant myths and reassuring employees and their families that deep research has proven the vaccines to be highly safe and effective.

Looking beyond the immediate concerns of COVID-19 vaccination and testing, this Action Brief revisits the potential long-term impact of the pandemic on employer baseline healthcare strategies. Recommendations for employers include how best to promote essential healthcare, implement benefits that fully integrate mental health care, and include telehealth options to remove care barriers.

This Action Brief provides practical things employers can do to help guide employees through uncertain times to ensure widespread vaccine adoption.

Advanced primary care (APC) delivers increased value for patients and purchasers by encompassing seven key attributes. Learn more about how APC leads to improved patient health, satisfaction and engagement; reduces unnecessary and emergency care; and has the potential to save 15% or more of overall healthcare spend.

 Medical imaging accounts for 10% of healthcare spending — or $100 billion. Yet, with their laser focus on the cost of imaging, many employers and other healthcare purchasers have lost sight of the larger picture — value. Learn how to define and achieve value in medical imaging to ensure the best possible cost and quality outcomes for patients and purchasers.

Special focus on immunizations

October 2020

Despite the fact that less than 2% of the US population uses biologic drugs, they account for 26% of national prescription drug spending.  Biosimilars can expand options, enhance affordability, and increase access to therapy.

June 2020

Adhering to evidence-based and value-based standards.

June 2020

Setting Price and Quality Expectations

January 2020

Advancing the Employers Role in Healthcare Quality and Safety

November 2019

Removing Barriers to Postpartum Depression Care

July 2019

Confronting a Misunderstood and Undermanaged Workforce Disease

June 2019

A Fresh Look at Benefit Design Considerations

May 2019